Event Details

Event Description

The Breast Cancer Course will discuss the evidence behind why we manage HER2 positive breast cancer the way we do in both the early and metastatic settings.

The field of breast cancer is ever advancing, with more and more treatments becoming available, resulting in better outcomes for our patients. The management of metastatic breast cancer has become increasingly complicated with more and more options for our patients. On this course we aim to discuss the evidence behind why we manage metastatic breast cancer the way we do.

This event is kindly sponsored by AstraZeneca who had no input into the content and agenda.

Objectives

• To learn about the management of metastatic breast cancer across all subtypes
• To learn about the structuring of, reasons behind and scope of an acute oncology service
• To reflect on any difficult cases you may have come across and discuss on their management

Who should attend

This course is designed for those who work in breast cancer, including medical and clinical oncologists, breast surgeons and breast care nurses. Those working in acute oncology or in chemotherapy units will also find the information helpful.

Agenda/find out more here

Book your place here